{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T06:45:43Z","timestamp":1792565143281,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bioenerg Biomembr"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10863-026-10131-z","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T06:15:16Z","timestamp":1792563316000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Upregulation of ZBTB20 indirectly participate in ferroptosis of Parkinson\u2019s disease by neuronal glial interactions"],"prefix":"10.1007","volume":"58","author":[{"given":"Xiaoli","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingge","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"key":"10131_CR1","doi-asserted-by":"publisher","unstructured":"Aarsland D, Batzu L, Halliday GM, Geurtsen GJ, Ballard C, Ray Chaudhuri K, Weintraub D\u00a0(2021) Parkinson disease-associated cognitive impairment.\u00a0Nat Rev Dis Primers\u00a07(1):47.\u00a0https:\/\/doi.org\/10.1038\/s41572-021-00280-3","DOI":"10.1038\/s41572-021-00280-3"},{"key":"10131_CR2","doi-asserted-by":"publisher","unstructured":"Alqahtani T, Deore SL, Kide AA, Shende BA, Sharma R, Chakole RD, Nemade LS, Kale NK, Borah S, Deokar SS, Behera A, Dhawal Bhandari D, Gaikwad N, Kalam Azad A, Ghosh A (2023)\u00a0Mitochondrial dysfunction and oxidative stress in Alzheimer\u2019s disease, and Parkinson\u2019s disease, Huntington\u2019s disease and amyotrophic lateral sclerosis-an updated review. Mitochondrion\u00a071:83\u201392.\u00a0https:\/\/doi.org\/10.1016\/j.mito.2023.05.007","DOI":"10.1016\/j.mito.2023.05.007"},{"key":"10131_CR3","doi-asserted-by":"publisher","unstructured":"Arya R, Haque AA, Shakya H, Billah MM, Parvin A, Rahman MM, Sakib KM, Faruquee HM, Kumar V, Kim JJ\u00a0(2024)\u00a0Parkinson\u2019s disease: biomarkers for diagnosis and disease progression. Int J Mol Sci\u00a025(22):12379.\u00a0https:\/\/doi.org\/10.3390\/ijms252212379","DOI":"10.3390\/ijms252212379"},{"key":"10131_CR4","doi-asserted-by":"publisher","unstructured":"Butt E, Howard CM, Raman D (2022) LASP1 in cellular signaling and gene expression: more than just a cytoskeletal regulator. Cells 11(23):3817.\u00a0https:\/\/doi.org\/10.3390\/cells11233817","DOI":"10.3390\/cells11233817"},{"key":"10131_CR5","doi-asserted-by":"publisher","unstructured":"Boag MK, Roberts A, Uversky VN, Ma L, Richardson DR, Pountney DL\u00a0(2022) Ferritinophagy and \u03b1-synuclein: Pharmacological targeting of autophagy to restore iron regulation in Parkinson's disease. Int J Mol Sci\u00a023(4):2378.\u00a0https:\/\/doi.org\/10.3390\/ijms23042378","DOI":"10.3390\/ijms23042378"},{"key":"10131_CR6","doi-asserted-by":"publisher","unstructured":"Bock MA, Brown EG, Zhang L, Tanner C\u00a0(2022)\u00a0Association of motor and nonmotor symptoms with health-related quality of life in a large online cohort of people with Parkinson disease.\u00a0Neurology 98(22):e2194\u2013e2203.\u00a0https:\/\/doi.org\/10.1212\/WNL.0000000000200113","DOI":"10.1212\/WNL.0000000000200113"},{"key":"10131_CR7","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2025.5803","author":"X Chen","year":"2025","unstructured":"Chen X, Luo M, Niu X, Wang W, Cao H, Zhang L, Wei R, Duan P (2025) ZBTB20 promotes ferroptosis through inhibiting TMEM109 expression in glioblastoma cells. Int J Oncol.67(6), 97. https:\/\/doi.org\/10.3892\/ijo.2025.5803","journal-title":"Int J Oncol"},{"key":"10131_CR8","doi-asserted-by":"publisher","unstructured":"Cui YH, Fu A, Wang XQ, Tu BX, Chen KZ, Wang YK, Hu QG, Wang LF, Hu ZL, Pan PH, Li F, Bi FF, Li CQ\u00a0(2021) Hippocampal LASP1 ameliorates chronic stress-mediated behavioral responses in a mouse model of unpredictable chronic mild stress. Neuropharmacology 184:108410.\u00a0https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108410","DOI":"10.1016\/j.neuropharm.2020.108410"},{"key":"10131_CR9","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.3892\/mmr.2017.6180","volume":"15","author":"J Deng","year":"2017","unstructured":"Deng J, Zhang W, Liu S, An H, Tan L, Ma L (2017) LATS1 suppresses proliferation and invasion of cervical cancer. Mol Med Rep 15:1654\u20131660","journal-title":"Mol Med Rep"},{"key":"10131_CR10","doi-asserted-by":"publisher","unstructured":"Dion\u00edsio PA, Amaral JD, Rodrigues CMP (2021) Oxidative stress and regulated cell death in Parkinson's disease. Ageing Res Rev\u00a067:101263.\u00a0https:\/\/doi.org\/10.1016\/j.arr.2021.101263","DOI":"10.1016\/j.arr.2021.101263"},{"key":"10131_CR11","doi-asserted-by":"publisher","unstructured":"Du G, Wang E, Sica C, Chen H, De Jesus S, Lewis MM, Kong L, Connor J, Mailman RB, Huang X\u00a0(2022)\u00a0Dynamics of nigral iron accumulation in Parkinson's disease: From diagnosis to late stage.\u00a0Movement disorders : official journal of the Movement Disorder Society, 37(8):1654\u20131662.\u00a0https:\/\/doi.org\/10.1002\/mds.29062","DOI":"10.1002\/mds.29062"},{"key":"10131_CR12","doi-asserted-by":"publisher","unstructured":"Gao Q, Zhou Y, Chen Y, Hu W, Jin W, Zhou C, Yuan H, Li J, Lin Z, Lin W\u00a0(2025) Role of iron in brain development, aging, and neurodegenerative diseases.\u00a0Ann Med\u00a057(1):2472871.\u00a0https:\/\/doi.org\/10.1080\/07853890.2025.2472871","DOI":"10.1080\/07853890.2025.2472871"},{"key":"10131_CR13","doi-asserted-by":"publisher","unstructured":"GBD 2016 Parkinson's Disease Collaborators (2018). Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. Neurology, 17(11), 939\u2013953 https:\/\/doi.org\/10.1016\/S1474-4422(18)30295-3","DOI":"10.1016\/S1474-4422(18)30295-3"},{"key":"10131_CR14","doi-asserted-by":"publisher","unstructured":"Guo X, Wei R, Yin X, Yang G (2025) Crosstalk between neuroinflammation and ferroptosis: Implications for Parkinson's disease progression. Front Pharmacol 16:1528538.\u00a0https:\/\/doi.org\/10.3389\/fphar.2025.1528538","DOI":"10.3389\/fphar.2025.1528538"},{"key":"10131_CR15","doi-asserted-by":"crossref","unstructured":"Han H, Nakaoka HJ, Hofmann L, Zhou JJ, Yu C, Zeng L, Nan J, Seo G, Vargas RE, Yang B, Qi R, Bardwell L, Fishman DA, Cho KWY, Huang L, Luo R, Warrior R, Wang W (2022a) The Hippo pathway kinases LATS1 and LATS2 attenuate cellular responses to heavy metals through phosphorylating MTF1. Nat Cell Biol 24:74\u201387","DOI":"10.1038\/s41556-021-00813-8"},{"key":"10131_CR16","doi-asserted-by":"crossref","unstructured":"Han X, Liu Y, Dai Y, Xu T, Hu Q, Yi X, Rui L, Hu G, Hu J (2022b) Neuronal SH2B1 attenuates apoptosis in an MPTP mouse model of Parkinson\u2019s disease via promoting PLIN4 degradation. Redox Biol 52:102308","DOI":"10.1016\/j.redox.2022.102308"},{"key":"10131_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41413-025-00414-3","volume":"13","author":"X Hao","year":"2025","unstructured":"Hao X, Zhao J, Jia L, Ding G, Liang X, Su F, Yang S, Yang Y, Fan J, Zhang WJ, Yang L and Jie Q (2025). LATS1-modulated ZBTB20 perturbing cartilage matrix homeostasis contributes to early-stage osteoarthritis. Bone Res 13(1):33 https:\/\/doi.org\/10.1038\/s41413-025-00414-3","journal-title":"Bone Res"},{"key":"10131_CR18","doi-asserted-by":"publisher","unstructured":"Jiao D, Yang Y, Wang K, Wang Y (2025) Ferroptosis: a novel pathogenesis and therapeutic strategies for Parkinson disease: A review. Medicine 104(3):e41218.\u00a0https:\/\/doi.org\/10.1097\/MD.0000000000041218","DOI":"10.1097\/MD.0000000000041218"},{"key":"10131_CR19","doi-asserted-by":"publisher","unstructured":"Jin J, Su D, Zhang J, Lam JS, Zhou J, Feng T\u00a0(2025 Iron deposition in subcortical nuclei of Parkinson's disease: A meta-analysis of quantitative iron-sensitive magnetic resonance imaging studies. Chin Med J\u00a0138(6):678\u2013692.\u00a0https:\/\/doi.org\/10.1097\/CM9.0000000000003167","DOI":"10.1097\/CM9.0000000000003167"},{"key":"10131_CR20","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1038\/s44319-025-00370-3","volume":"26","author":"JG Kern","year":"2025","unstructured":"Kern JG, Kroehling L, Spinella AJ, Monti S, Varelas X (2025) LATS1\/2 inactivation in the mammary epithelium drives the evolution of a tumor-associated niche. EMBO Rep 26:1472\u20131503","journal-title":"EMBO Rep"},{"key":"10131_CR21","doi-asserted-by":"publisher","unstructured":"Kushima I, Nakatochi M, Aleksic B, Okada T, Kimura H, Kato H, Morikawa M, Inada T, Ishizuka K, Torii Y, Nakamura Y, Tanaka S, Imaeda M, Takahashi N, Yamamoto M, Iwamoto K, Nawa Y, Ogawa N, Iritani S, Hayashi Y, \u2026 Ozaki N (2022) Cross-disorder analysis of genic and regulatory copy number variations in bipolar disorder, schizophrenia, and autism spectrum disorder. Biol Psychiatry 92(5):362\u2013374.\u00a0https:\/\/doi.org\/10.1016\/j.biopsych.2022.04.003","DOI":"10.1016\/j.biopsych.2022.04.003"},{"key":"10131_CR22","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1089\/ten.tea.2023.0091","volume":"30","author":"K Li","year":"2024","unstructured":"Li K, Liu L, Liu H, Xing J, Hu P, Song J (2024) LATS1\/YAP1 Axis Controls Bone Regeneration on Distraction Osteogenesis by Activating Wnt\/\u03b2-Catenin. Tissue Eng Part A 30:154\u2013167","journal-title":"Tissue Eng Part A"},{"key":"10131_CR23","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41422-021-00530-9","volume":"31","author":"RH Li","year":"2021","unstructured":"Li RH, Tian T, Ge QW, He XY, Shi CY, Li JH, Zhang Z, Liu FZ, Sang LJ, Yang ZZ, Liu YZ, Xiong Y, Yan Q, Li X, Ju HQ, Liu J, Wang LJ, Shao JZ, Wang W, Zhou T, Lin A (2021) A phosphatidic acid-binding lncRNA SNHG9 facilitates LATS1 liquid-liquid phase separation to promote oncogenic YAP signaling. Cell Res 31:1088\u20131105","journal-title":"Cell Res"},{"key":"10131_CR24","doi-asserted-by":"publisher","unstructured":"Li Y, Lv Z, Dai Y, Yu L, Zhang L, Wang K, Hu P\u00a0(2025).The global, regional, and National burden of parkinson's disease in 204 countries and territories, 1990-2021: a systematic analysis for the global burden of disease study 2021.\u00a0BMC Public Health\u00a025(1):3047.\u00a0https:\/\/doi.org\/10.1186\/s12889-025-23492-8","DOI":"10.1186\/s12889-025-23492-8"},{"key":"10131_CR25","doi-asserted-by":"publisher","unstructured":"Macedo VF, Macedo VK, de Miranda Coelho JA, de Melo Barboza AM\u00a0(2025) Parkinson's disease physiopathology-beyond the \u03b1-synuclein aggregation: a narrative review.\u00a0Front Aging Neurosci\u00a017:1664269.\u00a0https:\/\/doi.org\/10.3389\/fnagi.2025.1664269","DOI":"10.3389\/fnagi.2025.1664269"},{"key":"10131_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.brainresbull.2020.10.019","volume":"166","author":"X Ma","year":"2021","unstructured":"Ma X, Zhang H, Yin H, Geng S, Liu Y, Liu C, Zhao J, Liu Y, Wang X, Wang Y (2021) Up-regulated microRNA-218-5p ameliorates the damage of dopaminergic neurons in rats with Parkinson\u2019s disease via suppression of LASP1. Brain Res Bull 166:92\u2013101","journal-title":"Brain Res Bull"},{"key":"10131_CR27","doi-asserted-by":"publisher","unstructured":"Morris HR, Spillantini MG, Sue CM, Williams-Gray CH\u00a0(2024) The pathogenesis of Parkinson's disease. Lancet 403(10423):293\u2013304.\u00a0https:\/\/doi.org\/10.1016\/S0140-6736(23)01478-2","DOI":"10.1016\/S0140-6736(23)01478-2"},{"key":"10131_CR28","doi-asserted-by":"publisher","first-page":"11102","DOI":"10.1038\/ncomms11102","volume":"7","author":"M Nagao","year":"2016","unstructured":"Nagao M, Ogata T, Sawada Y, Gotoh Y (2016) Zbtb20 promotes astrocytogenesis during neocortical development. Nat Commun 7:11102","journal-title":"Nat Commun"},{"key":"10131_CR29","doi-asserted-by":"publisher","unstructured":"Pe\u00f1a-Zelayeta L, Delgado-Minjares KM, Villegas-Rojas MM, Le\u00f3n-Arcia K, Santiago-Balmaseda A, Andrade-Guerrero J, P\u00e9rez-Segura I, Ortega-Robles E, Soto-Rojas LO, Arias-Carri\u00f3n O\u00a0(2025) Redefining Non-Motor Symptoms in Parkinson's Disease.\u00a0J Pers Med\u00a015(5):172.\u00a0https:\/\/doi.org\/10.3390\/jpm15050172","DOI":"10.3390\/jpm15050172"},{"key":"10131_CR30","doi-asserted-by":"publisher","unstructured":"Peterson ML, Ma C, Spear BT\u00a0(2011) Zhx2 and Zbtb20: novel regulators of postnatal alpha-fetoprotein repression and their potential role in gene reactivation during liver cancer.\u00a0Semin Cancer Biol\u00a021(1):21\u201327.\u00a0https:\/\/doi.org\/10.1016\/j.semcancer.2011.01.001","DOI":"10.1016\/j.semcancer.2011.01.001"},{"key":"10131_CR31","doi-asserted-by":"publisher","unstructured":"Picca A, Guerra F, Calvani R, Romano R, Coelho-J\u00fanior HJ, Bucci C, Marzetti E\u00a0(2021)\u00a0Mitochondrial dysfunction, protein misfolding and neuroinflammation in Parkinson's disease: roads to biomarker discovery. Biomolecules\u00a011(10):1508.\u00a0https:\/\/doi.org\/10.3390\/biom11101508","DOI":"10.3390\/biom11101508"},{"key":"10131_CR32","doi-asserted-by":"publisher","unstructured":"Schwabenland M, Br\u00fcck W, Priller J, Stadelmann C, Lassmann H, Prinz M (2021) Analyzing microglial phenotypes across neuropathologies: a practical guide. Acta Neuropathol 142(6):923\u2013936.\u00a0https:\/\/doi.org\/10.1007\/s00401-021-02370-8","DOI":"10.1007\/s00401-021-02370-8"},{"key":"10131_CR33","doi-asserted-by":"publisher","unstructured":"Su D, Cui Y, He C, Yin P, Bai R, Zhu J, Lam JST, Zhang J, Yan R, Zheng X, Wu J, Zhao D, Wang A, Zhou M, Feng T\u00a0(2025) Projections for prevalence of Parkinson's disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021. BMJ 388:e080952.\u00a0https:\/\/doi.org\/10.1136\/bmj-2024-080952","DOI":"10.1136\/bmj-2024-080952"},{"key":"10131_CR34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2118818119","author":"CP Sun","year":"2022","unstructured":"Sun CP, Zhou JJ, Yu ZL, Huo XK, Zhang J, Morisseau C, Hammock BD, Ma XC (2022) Kurarinone alleviated Parkinson\u2019s disease via stabilization of epoxyeicosatrienoic acids in animal model. Proc Natl Acad Sci U S A.119(9), e2118818119. https:\/\/doi.org\/10.1073\/pnas.2118818119","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10131_CR35","doi-asserted-by":"publisher","unstructured":"Sun J, Lin XM, Lu DH, Wang M, Li K, Li SR, Li ZQ, Zhu CJ, Zhang ZM, Yan CY, Pan MH, Gong HB, Feng JC, Cao YF, Huang F, Sun WY, Kurihara H, Li YF, Duan WJ, Jiao GL,\u00a0\u2026 He RR (2023) Midbrain dopamine oxidation links ubiquitination of glutathione peroxidase 4 to ferroptosis of dopaminergic neurons.\u00a0J Clin Invest 133(10):e165228.\u00a0https:\/\/doi.org\/10.1172\/JCI165228","DOI":"10.1172\/JCI165228"},{"key":"10131_CR36","doi-asserted-by":"publisher","unstructured":"Sohrabi T, Mirzaei-Behbahani B, Zadali R, Pirhaghi M, Morozova-Roche LA, Meratan AA\u00a0(2023) Common\u00a0mechanisms underlying \u03b1-synuclein-induced mitochondrial dysfunction in Parkinson's disease.\u00a0J Mol Biol\u00a0435(12):167992.\u00a0https:\/\/doi.org\/10.1016\/j.jmb.2023.167992","DOI":"10.1016\/j.jmb.2023.167992"},{"key":"10131_CR37","doi-asserted-by":"publisher","unstructured":"Tanner CM, Ostrem JL\u00a0(2024) Parkinson's disease.\u00a0N Engl J Med\u00a0391(5):442\u2013452.\u00a0https:\/\/doi.org\/10.1056\/NEJMra2401857","DOI":"10.1056\/NEJMra2401857"},{"key":"10131_CR38","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5590855","volume":"2021","author":"J Tao","year":"2021","unstructured":"Tao J, Qiu J, Lu L, Zhang L, Fu Y, Wang M, Han J, Shi M, Li L, Zhao Z, Wei F, Wang C, Zhang H, Liang S, Zheng J (2021) ZBTB20 positively regulates oxidative stress, mitochondrial fission, and inflammatory responses of ox-LDL-induced macrophages in atherosclerosis. Oxid Med Cell Longev 2021:5590855","journal-title":"Oxid Med Cell Longev"},{"key":"10131_CR39","doi-asserted-by":"publisher","unstructured":"\u00a0Teferi N, Challa M, Woodiwiss T, Allen B, Petronek M (2023) Mitochondrial dysfunction, iron accumulation, and ferroptosis in Parkinson's disease.\u00a0Redox Exp Med\u00a02023(1).\u00a0https:\/\/doi.org\/10.1530\/REM-23-0004","DOI":"10.1530\/REM-23-0004"},{"key":"10131_CR40","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.freeradbiomed.2024.02.023","volume":"216","author":"L Wang","year":"2024","unstructured":"Wang L, Tian S, Ruan S, Wei J, Wei S, Chen W, Hu H, Qin W, Li Y, Yuan H, Mao J, Xu Y, Xie J (2024) Neuroprotective effects of cordycepin on MPTP-induced Parkinson\u2019s disease mice via suppressing PI3K\/AKT\/mTOR and MAPK-mediated neuroinflammation. Free Radic Biol Med 216:60\u201377","journal-title":"Free Radic Biol Med"},{"key":"10131_CR41","doi-asserted-by":"publisher","unstructured":"Wang Y, Sun B, Shibata B, Guo F (2022a) Transmission electron microscopic analysis of myelination in the murine central nervous system.\u00a0STAR Protoc\u00a03(2):101304.\u00a0https:\/\/doi.org\/10.1016\/j.xpro.2022.101304","DOI":"10.1016\/j.xpro.2022.101304"},{"key":"10131_CR42","doi-asserted-by":"crossref","unstructured":"Wang ZL, Yuan L, Li W, Li JY (2022b) Ferroptosis in Parkinson\u2019s disease: glia-neuron crosstalk. Trends Mol Med 28:258\u2013269","DOI":"10.1016\/j.molmed.2022.02.003"},{"key":"10131_CR43","doi-asserted-by":"publisher","unstructured":"Xiao B, Zhou Z, Chao Y, Tan EK\u00a0(2025) Pathogenesis of Parkinson's disease. Neurol Clin\u00a043(2):185\u2013207.\u00a0https:\/\/doi.org\/10.1016\/j.ncl.2024.12.003","DOI":"10.1016\/j.ncl.2024.12.003"},{"key":"10131_CR44","doi-asserted-by":"publisher","unstructured":"Yang L, Cheng Y, Sun Y, Xuan Y, Niu J, Guan J, Rong Y, Jia Y, Zhuang Z, Yan G, Wu R (2022) Combined application of quantitative susceptibility mapping and diffusion kurtosis imaging techniques to investigate the effect of iron deposition on microstructural changes in the brain in Parkinson's disease. Front Aging Neurosci 14:792778.\u00a0https:\/\/doi.org\/10.3389\/fnagi.2022.792778","DOI":"10.3389\/fnagi.2022.792778"},{"key":"10131_CR45","doi-asserted-by":"publisher","unstructured":"Zhang H, Cao D, Zhou L, Zhang Y, Guo X, Li H, Chen Y, Spear BT, Wu JW, Xie Z, Zhang WJ (2015) ZBTB20 is a sequence-specific transcriptional repressor of alpha-fetoprotein gene. Scientific reports 5:11979.\u00a0https:\/\/doi.org\/10.1038\/srep11979","DOI":"10.1038\/srep11979"},{"key":"10131_CR46","doi-asserted-by":"publisher","unstructured":"Zhang H, Shi JH, Jiang H, Wang K, Lu JY, Jiang X, Ma X, Chen YX, Ren AJ, Zheng J, Xie Z (2018) ZBTB20 regulates EGFR expression and hepatocyte proliferation in mouse liver regeneration. Cell Death Dis 9(5):462.\u00a0https:\/\/doi.org\/10.1038\/s41419-018-0514-0","DOI":"10.1038\/s41419-018-0514-0"},{"key":"10131_CR47","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41531-025-00995-0","volume":"11","author":"S Zhang","year":"2025","unstructured":"Zhang S, Yan M, Jiang X, Liu Y, Ma W, Ding L, Lu Z, Luo Y, Tian X, Wang Q (2025) Oligodendrocyte-astrocyte crosstalk in Parkinson\u2019s disease mediates neuronal ferroptosis via the FGF signaling pathway. NPJ Parkinsons Dis 11:136","journal-title":"NPJ Parkinsons Dis"},{"key":"10131_CR48","doi-asserted-by":"publisher","unstructured":"Zheng Z, Zhu Z, Zhou C, Cao L, Zhao G (2023) Burden of Parkinson Disease in China, 1990-2019: Findings from the 2019 Global Burden of Disease Study. Neuroepidemiology 57(1):51\u201364.\u00a0https:\/\/doi.org\/10.1159\/000527372","DOI":"10.1159\/000527372"},{"key":"10131_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252313042","author":"M Zhou","year":"2024","unstructured":"Zhou M, Xu K, Ge J, Luo X, Wu M, Wang N, Zeng J (2024) Targeting ferroptosis in Parkinson\u2019s disease: mechanisms and emerging therapeutic strategies. Int J Mol Sci.25(23), 13042. https:\/\/doi.org\/10.3390\/ijms252313042","journal-title":"Int J Mol Sci"},{"key":"10131_CR50","doi-asserted-by":"publisher","unstructured":"\u00a0Zhang S, Wang T, Peng Y, Wang Q, Zhang Z, Chu S, Huang H, Chen N (2026) Parkinson's disease: pathogenesis and therapeutic strategies. Mol Biomed\u00a07(1):46.\u00a0https:\/\/doi.org\/10.1186\/s43556-026-00445-0","DOI":"10.1186\/s43556-026-00445-0"}],"container-title":["Journal of Bioenergetics and Biomembranes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10863-026-10131-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10863-026-10131-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10863-026-10131-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T06:15:17Z","timestamp":1792563317000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10863-026-10131-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["10131"],"URL":"https:\/\/doi.org\/10.1007\/s10863-026-10131-z","relation":{},"ISSN":["0145-479X","1573-6881"],"issn-type":[{"value":"0145-479X","type":"print"},{"value":"1573-6881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,21]]},"assertion":[{"value":"10 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments was approved by ethical committee (XinRui-DWLL-20240812021) and strictly implemented in compliance with the NIH Guide for the Care and Use of Laboratory Animals. All procedures were performed in accordance with ARRIVE guidelines.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"59"}}